These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 37394588

  • 1. LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease.
    Lee J, Kim H, Kang YW, Kim Y, Park MY, Song JH, Jo Y, Dao T, Ryu D, Lee J, Oh CM, Park S.
    Exp Mol Med; 2023 Jul; 55(7):1479-1491. PubMed ID: 37394588
    [Abstract] [Full Text] [Related]

  • 2. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease.
    Guo L, Guo YY, Li BY, Peng WQ, Chang XX, Gao X, Tang QQ.
    J Biol Chem; 2019 Aug 02; 294(31):11805-11816. PubMed ID: 31197036
    [Abstract] [Full Text] [Related]

  • 3. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS, An TH, Kim H, Jung E, Kim G, Oh SY, Kim JS, Chun HJ, Jung J, Lee EW, Han BS, Han DH, Lee YH, Han TS, Hur K, Lee CH, Kim DS, Kim WK, Park JW, Koo SH, Seong JK, Lee SC, Kim H, Bae KH, Oh KJ.
    Diabetologia; 2023 May 02; 66(5):931-954. PubMed ID: 36759348
    [Abstract] [Full Text] [Related]

  • 4. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J, Xia M, Xue Y, Ma F, Cui A, Sun Y, Han Y, Xu X, Zhang F, Hu Z, Liu Z, Liu Y, Cai G, Su W, Sun X, Wu H, Yan H, Chang X, Hu X, Bian H, Xia P, Gao J, Li Y, Gao X.
    EBioMedicine; 2020 Jul 02; 57():102849. PubMed ID: 32580141
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
    Yin X, Liu Z, Wang J.
    Phytomedicine; 2023 Oct 02; 119():155005. PubMed ID: 37562090
    [Abstract] [Full Text] [Related]

  • 8. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
    Han HS, Kim SG, Kim YS, Jang SH, Kwon Y, Choi D, Huh T, Moon E, Ahn E, Seong JK, Kweon HS, Hwang GS, Lee DH, Cho KW, Koo SH.
    Mol Metab; 2022 Jan 02; 55():101402. PubMed ID: 34838715
    [Abstract] [Full Text] [Related]

  • 9. Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice.
    Tryndyak VP, Willett RA, Nagumalli SK, Li D, Avigan MI, Beland FA, Rusyn I, Pogribny IP.
    Am J Physiol Gastrointest Liver Physiol; 2023 Mar 01; 324(3):G232-G243. PubMed ID: 36625475
    [Abstract] [Full Text] [Related]

  • 10. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
    Kim S, Hong J, Jeon R, Kim HS.
    Nutr Res; 2016 Jan 01; 36(1):90-100. PubMed ID: 26773785
    [Abstract] [Full Text] [Related]

  • 11. Role of liquid fructose/sucrose in regulating the hepatic transcriptome in a high-fat Western diet model of NAFLD.
    Luo Y, Woodie LN, Graff EC, Zhang J, Fowler S, Wang X, Wang X, O'Neill AM, Greene MW.
    J Nutr Biochem; 2023 Feb 01; 112():109174. PubMed ID: 36280127
    [Abstract] [Full Text] [Related]

  • 12. Sex-specific maternal calcium requirements for the prevention of nonalcoholic fatty liver disease by altering the intestinal microbiota and lipid metabolism in the high-fat-diet-fed offspring mice.
    Li P, Yan K, Chang X, Chen X, Wang R, Fan X, Tang T, Zhan D, Qi K.
    Gut Microbes; 2020 Nov 01; 11(6):1590-1607. PubMed ID: 32576050
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NME4 mediates metabolic reprogramming and promotes nonalcoholic fatty liver disease progression.
    Xie S, Yuan L, Sui Y, Feng S, Li H, Li X.
    EMBO Rep; 2024 Jan 01; 25(1):378-403. PubMed ID: 38177901
    [Abstract] [Full Text] [Related]

  • 18. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y, Choi SI, Hong E, Kim GH.
    J Food Sci; 2020 Jul 01; 85(7):2216-2226. PubMed ID: 32579753
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse model.
    Xu L, Kim JK, Bai Q, Zhang X, Kakiyama G, Min HK, Sanyal AJ, Pandak WM, Ren S.
    Mol Pharmacol; 2013 Mar 01; 83(3):648-58. PubMed ID: 23258548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.